Korro Bio's market cap is currently $268.40M. The company's EPS TTM is $-12.016; its P/E ratio is ―; Korro Bio is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-2.50. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 14.07M	$ 36.98M	$ 28.95M
Gross Profit	$ -3.63M	$ -2.51M	$ 10.23M	$ 35.40M	$ 12.13M
Operating Income	$ -84.53M	$ -59.00M	$ -35.49M	$ -27.55M	$ -20.68M
EBITDA	$ -80.90M	$ -56.49M	$ -33.90M	$ -24.90M	$ -17.93M
Net Income	$ -81.17M	$ -58.03M	$ -21.96M	$ -26.51M	$ -18.75M
Balance Sheet
Cash & Short-Term Investments	$ 166.15M	$ 55.25M	$ 118.53M	$ 220.34M	$ 217.35M
Total Assets	$ 221.66M	$ 73.74M	$ 127.58M	$ 264.72M	$ 223.22M
Total Debt	$ 33.21M	$ 3.13M	$ 45.60M	$ 45.99M	$ 0.00
Net Debt	$ -132.94M	$ -33.20M	$ -37.89M	$ -174.35M	$ -200.16M
Total Liabilities	$ 51.75M	$ 172.77M	$ 169.78M	$ 72.23M	$ 55.86M
Stockholders' Equity	$ 169.91M	$ -99.03M	$ -42.21M	$ 192.49M	$ 167.36M
Cash Flow
Free Cash Flow	$ -75.12M	$ -58.86M	$ -36.54M	$ -51.86M	$ 33.15M
Operating Cash Flow	$ -67.28M	$ -53.65M	$ -32.09M	$ -45.19M	$ 34.22M
Investing Cash Flow	$ 11.16M	$ 11.06M	$ -39.50M	$ 10.40M	$ -18.26M
Financing Cash Flow	$ 187.76M	$ 18.00K	$ 115.94M	$ 56.69M	$ 142.01M

Currency in USD

Korro Bio Earnings and Revenue History

Income Statement >

Korro Bio Debt to Assets

Balance Sheet >

Korro Bio Cash Flow

Cash Flow >

Korro Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing